Principal Financial Group Inc. Invests $361,000 in Semler Scientific, Inc. (NASDAQ:SMLR)

Principal Financial Group Inc. purchased a new stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 15,343 shares of the company's stock, valued at approximately $361,000. Principal Financial Group Inc. owned 0.22% of Semler Scientific at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of SMLR. BOKF NA acquired a new stake in Semler Scientific during the 1st quarter worth approximately $227,000. Jacobs Levy Equity Management Inc. raised its stake in shares of Semler Scientific by 20.6% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 98,252 shares of the company's stock valued at $2,870,000 after acquiring an additional 16,777 shares during the period. CWM LLC lifted its holdings in shares of Semler Scientific by 486.3% during the 2nd quarter. CWM LLC now owns 897 shares of the company's stock valued at $31,000 after acquiring an additional 744 shares in the last quarter. Financial Strategies Group Inc. purchased a new stake in Semler Scientific during the 2nd quarter worth $263,000. Finally, Bank of New York Mellon Corp increased its holdings in Semler Scientific by 10.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 20,618 shares of the company's stock valued at $709,000 after purchasing an additional 1,940 shares in the last quarter. 49.37% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Semler Scientific

In other Semler Scientific news, CEO Douglas Murphy-Chutorian sold 10,000 shares of Semler Scientific stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total transaction of $283,500.00. Following the sale, the chief executive officer now directly owns 60,220 shares in the company, valued at $1,707,237. The trade was a 14.24 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 30.20% of the company's stock.

Semler Scientific Trading Down 3.8 %

Shares of SMLR traded down $2.42 during midday trading on Monday, reaching $61.23. 1,754,456 shares of the company were exchanged, compared to its average volume of 248,784. Semler Scientific, Inc. has a 1-year low of $20.88 and a 1-year high of $79.45. The stock has a 50-day moving average price of $32.45 and a 200-day moving average price of $30.85. The company has a market cap of $445.14 million, a price-to-earnings ratio of 29.87 and a beta of 0.92.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The firm had revenue of $13.51 million for the quarter.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.